Keyphrases
Lupus
69%
Systemic Lupus Erythematosus
68%
Systemic Lupus Erythematosus Patient
46%
Health-related Quality of Life
45%
Peruvian
37%
SLE Disease Activity Index (SLEDAI)
32%
Damage Accrual
25%
COVID-19
22%
Disease Activity
21%
Disease Duration
20%
Remission
20%
Age at Diagnosis
19%
Damage Index
18%
Latin American
17%
Patient Data
16%
Medical Students
16%
Lupus Low Disease Activity State (LLDAS)
14%
Rheumatology
14%
Visual Analog Scale
14%
COVID-19 Pandemic
14%
Disease Activity Score
13%
Multivariable
13%
Systemic Lupus International Collaborating Clinics
12%
Prednisone
11%
Rheumatic Diseases
11%
Homocysteine Levels
11%
Low Disease Activity State
11%
Living with
11%
Fear of Coronavirus
11%
Psychometric Properties
11%
Spanish Version
11%
SLICC
10%
Emotional Health
10%
LupusQoL
9%
Numerical Rating Scale
9%
Single Center
9%
Physical Health
9%
Mental Health
8%
Mestizo
7%
American College of Rheumatology
7%
Activity State
7%
Fear of COVID-19 Scale (FCV-19S)
7%
Immunosuppressive Drugs
6%
Patient-Reported Outcomes Measurement Information System (PROMIS)
6%
Hospitalization
6%
Multivariable Model
6%
Regression Analysis
6%
Latin America (LATAM)
6%
Rheumatologists
6%
Leg Fat
5%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
64%
Disease Activity
40%
Quality of Life
37%
SLEDAI
20%
Rheumatology
18%
Disease Duration
14%
Symptom
11%
Homocysteine
11%
Patient-Data
11%
COVID-19
11%
Prednisone
10%
Visual Analog Scale
9%
Rheumatic Disease
9%
Antimalarial Agent
8%
Disease
8%
Numeric Rating Scale
7%
Immunosuppressive Drug
7%
Observational Study
6%
Glucocorticoid
6%
Emotional Stability
6%
Disease Activity Score
5%
Frailty
5%
Meta-Regression
5%
Metabolic Syndrome
5%
Systematic Review
5%
Psychiatry
5%
Susac Syndrome
5%
Catatonia
5%
Uric Acid
5%
Salmonella
5%
Self Concept
5%
Personal Experience
5%
Osteomyelitis
5%
